Literature DB >> 17304147

Comparison of urinary on-site immunoassay screening and gas chromatography-mass spectrometry results of 111 patients with suspected poisoning presenting at an emergency department.

Marc-A von Mach1, Carola Weber, Markus R Meyer, Ludwig S Weilemann, Hans H Maurer, Frank T Peters.   

Abstract

On-site tests based on immunoassay techniques are widely used for toxicologic screening analysis in patients with suspected poisoning. However, such assays usually have been validated using urine samples with known concentrations of the investigated substances. In the present investigation, on-site screening results were evaluated in a clinical setting. This was a retrospective study of patients with suspected poisoning from January to December 2003 in the emergency department of a tertiary urban hospital. Urine samples were analyzed using the Triage 8 panel and gas chromatography-mass spectrometry (GC-MS). A total of 111 patients were included (54 female, 57 male; average age 37.8 +/- 19.7 years). A total of 3.8% of the patients showed no symptoms, 45.2% minor, 24.0% moderate, and 26.9% serious symptoms. In 50 patients (45.0%), Triage 8 results corresponded well with GC-MS results. In 17 patients (15.3%), the Triage 8 results were confirmed by GC-MS, but additional substances were determined that could not be detected by the Triage 8 panel. A completely negative Triage 8 screening result was obtained in 23 patients (20.7%) who showed toxicologically relevant findings in GC-MS. In 21 patients (18.9%), Triage 8 results could not be confirmed by GC-MS. The analysis of the results in view of the patients' medical histories revealed that in 20 patients (18.0%), no relevant toxic substance could be detected. Additionally, 8 patients (7.2%) showed intoxication with alcohol, which could not be detected by the presently applied toxicologic screening investigations. On-site screening results in suspected poisoning were not very helpful in the present study because practically every second patient ingested substances that were not detectable by the Triage 8 device. In addition, every fifth result was not in line with GC-MS findings. On-site test findings should be interpreted very carefully, and in critical cases, a GC-MS screening should be performed.

Entities:  

Mesh:

Year:  2007        PMID: 17304147     DOI: 10.1097/FTD.0b013e31802bb2aa

Source DB:  PubMed          Journal:  Ther Drug Monit        ISSN: 0163-4356            Impact factor:   3.681


  4 in total

1.  Buyer Beware: Pitfalls in Toxicology Laboratory Testing.

Authors:  D Adam Algren; Michael R Christian
Journal:  Mo Med       Date:  2015 May-Jun

2.  Fatal toxicity index of medicinal drugs based on a comprehensive toxicology database.

Authors:  Ilkka Ojanperä; Pirkko Kriikku; Erkki Vuori
Journal:  Int J Legal Med       Date:  2016-03-17       Impact factor: 2.686

3.  The antipsychotic story: changes in prescriptions and overdose without better safety.

Authors:  Ingrid Berling; Nicholas A Buckley; Geoffrey K Isbister
Journal:  Br J Clin Pharmacol       Date:  2016-04-15       Impact factor: 4.335

4.  Clinical value of drugs of abuse point of care testing in an emergency department setting.

Authors:  P S Lager; M E Attema-de Jonge; M P Gorzeman; L E Kerkvliet; E J F Franssen
Journal:  Toxicol Rep       Date:  2017-12-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.